159 related articles for article (PubMed ID: 20531984)
41. Endogenous CCN5 Participates in Angiotensin II/TGF-β
Huang A; Li H; Zeng C; Chen W; Wei L; Liu Y; Qi X
Front Pharmacol; 2020; 11():1235. PubMed ID: 33013358
[TBL] [Abstract][Full Text] [Related]
42. Differential roles of CCN family proteins during osteoblast differentiation: Involvement of Smad and MAPK signaling pathways.
Kawaki H; Kubota S; Suzuki A; Suzuki M; Kohsaka K; Hoshi K; Fujii T; Lazar N; Ohgawara T; Maeda T; Perbal B; Takano-Yamamoto T; Takigawa M
Bone; 2011 Nov; 49(5):975-89. PubMed ID: 21763478
[TBL] [Abstract][Full Text] [Related]
43. Tissue distribution and transcriptional regulation of CCN5 in the heart after myocardial infarction.
Zolfaghari S; Kaasbøll OJ; Ahmed MS; Line FA; Hagelin EMV; Monsen VT; Attramadal H
J Cell Commun Signal; 2022 Sep; 16(3):377-395. PubMed ID: 34854055
[TBL] [Abstract][Full Text] [Related]
44. Estrogen induces CCN5 expression in the rat uterus in vivo.
Mason HR; Grove-Strawser D; Rubin BS; Nowak RA; Castellot JJ
Endocrinology; 2004 Feb; 145(2):976-82. PubMed ID: 14605002
[TBL] [Abstract][Full Text] [Related]
45. CCN5/WISP2 and metabolic diseases.
Grünberg JR; Elvin J; Paul A; Hedjazifar S; Hammarstedt A; Smith U
J Cell Commun Signal; 2018 Mar; 12(1):309-318. PubMed ID: 29247377
[TBL] [Abstract][Full Text] [Related]
46. Spatial-temporal modulation of CCN proteins during wound healing in human skin in vivo.
Rittié L; Perbal B; Castellot JJ; Orringer JS; Voorhees JJ; Fisher GJ
J Cell Commun Signal; 2011 Mar; 5(1):69-80. PubMed ID: 21484592
[TBL] [Abstract][Full Text] [Related]
47. Recombinant protein CCN5/WISP2 promotes islet cell proliferation and survival
Kaddour N; Zhang D; Gao ZH; Liu JL
Growth Factors; 2019 Aug; 37(3-4):120-130. PubMed ID: 31437074
[TBL] [Abstract][Full Text] [Related]
48. The matricellular protein CCN5 induces apoptosis in myofibroblasts through SMAD7-mediated inhibition of NFκB.
Nguyen MT; Lee MA; Kim YK; Kook H; Jeong D; Jang SP; Kwak TH; Park WJ
PLoS One; 2022; 17(8):e0269735. PubMed ID: 35917315
[TBL] [Abstract][Full Text] [Related]
49. CCN5 in alveolar epithelial proliferation and differentiation during neonatal lung oxygen injury.
Fiaturi N; Russo JW; Nielsen HC; Castellot JJ
J Cell Commun Signal; 2018 Mar; 12(1):217-229. PubMed ID: 29349730
[TBL] [Abstract][Full Text] [Related]
50. CCN5 inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells.
Sun S; Cui Z; Yan T; Wu J; Liu Z
Cell Biol Int; 2020 Apr; 44(4):998-1008. PubMed ID: 31889370
[TBL] [Abstract][Full Text] [Related]
51. Nuclear trafficking of photoreceptor protein crx: the targeting sequence and pathologic implications.
Fei Y; Hughes TE
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2849-56. PubMed ID: 10967037
[TBL] [Abstract][Full Text] [Related]
52. Metabolic Effects of CCN5/WISP2 Gene Deficiency and Transgenic Overexpression in Mice.
Alami T; Liu JL
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948212
[TBL] [Abstract][Full Text] [Related]
53. CCN5 Reduces Ligamentum Flavum Hypertrophy by Modulating the TGF-β Pathway.
Ye S; Kwon WK; Bae T; Kim S; Lee JB; Cho TH; Park JY; Kim K; Hur JK; Hur JW
J Orthop Res; 2019 Dec; 37(12):2634-2644. PubMed ID: 31334871
[TBL] [Abstract][Full Text] [Related]
54. [Effects of CCN5 overexpression on the expression of alpha-SMA and collagen I in hepatic stellate cells and its mechanism].
Zhang CY; Xie X; Gao DS; Zhang CX
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Sep; 29(5):411-5. PubMed ID: 24386815
[TBL] [Abstract][Full Text] [Related]
55. Protective effect of estrogen receptors (ERα/β) against the intervertebral disc degeneration involves activating CCN5 via the promoter.
Song MX; Ma XX; Wang C; Wang Y; Sun C; Xu DR; Zhu K; Li GH; Zhao H; Zhang C
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1811-1820. PubMed ID: 33660790
[TBL] [Abstract][Full Text] [Related]
56. CCN5/WISP-2 restores ER-∝ in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifen.
Sarkar S; Ghosh A; Banerjee S; Maity G; Das A; Larson MA; Gupta V; Haque I; Tawfik O; Banerjee SK
Oncogenesis; 2017 May; 6(5):e340. PubMed ID: 28530705
[TBL] [Abstract][Full Text] [Related]
57. Biological characteristics of CCN proteins in tumor development.
Barreto SC; Ray A; Ag Edgar P
J BUON; 2016; 21(6):1359-1367. PubMed ID: 28039692
[TBL] [Abstract][Full Text] [Related]
58. Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors.
Guillon-Munos A; Oikonomopoulou K; Michel N; Smith CR; Petit-Courty A; Canepa S; Reverdiau P; Heuzé-Vourc'h N; Diamandis EP; Courty Y
J Biol Chem; 2011 Jul; 286(29):25505-18. PubMed ID: 21628462
[TBL] [Abstract][Full Text] [Related]
59. CCN5 activation by free or encapsulated EGCG is required to render triple-negative breast cancer cell viability and tumor progression.
Das A; Haque I; Ray P; Ghosh A; Dutta D; Quadir M; De A; Gunewardena S; Chatterjee I; Banerjee S; Weir S; Banerjee SK
Pharmacol Res Perspect; 2021 Apr; 9(2):e00753. PubMed ID: 33745223
[TBL] [Abstract][Full Text] [Related]
60. CCN family of proteins: critical modulators of the tumor cell microenvironment.
Yeger H; Perbal B
J Cell Commun Signal; 2016 Sep; 10(3):229-240. PubMed ID: 27517291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
